Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Hurt-Camejo

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Trends in Cardiovascular Medicine|November 30, 2000
Modification of plasma lipoproteins by group IIA phospholipase A(2): possible implications for atherogenesisP Sartipy, E Hurt-Camejo
Investigacion Clinica|June 22, 2001
[Why are plasmatic apoB lipoproteins atherogenic? The hypothesis of response to retention]E Hurt-Camejo, G Camejo
Arteriosclerosis, Thrombosis, and Vascular Biology|December 16, 1998
Phospholipase A2 type II binds to extracellular matrix biglycan: modulation of its activity on LDL by colocalization in glycosaminoglycan matrixesP Sartipy, G Bondjers, E Hurt-Camejo
Current Opinion in Lipidology|October 26, 2000
Phospholipase A2 and small, dense low-density lipoproteinE Hurt-Camejo, G Camejo, P Sartipy
Atherosclerosis|June 11, 1998
Lysophosphatidylcholine induces the production of IL-1beta by human monocytesY Liu-Wu, E Hurt-Camejo, O Wiklund
Journal of Internal Medicine|May 15, 2001
Cell adhesion molecules and secretory type II phospholipase A2 in relation to carotid atherosclerosis in patients with hypercholesterolaemiaO Wiklund, J Hulthe, G Bondjers, et al.
Circulation Research|April 4, 2000
Molecular basis for the association of group IIA phospholipase A(2) and decorin in human atherosclerotic lesionsP Sartipy, B Johansen, K Gâsvik, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 29, 1998
Ultrastructural localization of secretory type II phospholipase A2 in atherosclerotic and nonatherosclerotic regions of human arteriesM Romano, E Romano, S Björkerud, et al.
The Journal of Biological Chemistry|August 28, 1999
Phospholipase A(2) modification of low density lipoproteins forms small high density particles with increased affinity for proteoglycans and glycosaminoglycansP Sartipy, G Camejo, L Svensson, et al.
The Journal of Biological Chemistry|May 16, 2000
Interferon-gamma induces secretory group IIA phospholipase A2 in human arterial smooth muscle cells. Involvement of cell differentiation, STAT-3 activation, and modulation by other cytokinesH Peilot, B Rosengren, G Bondjers, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Trends in Cardiovascular Medicine|November 30, 2000
Modification of plasma lipoproteins by group IIA phospholipase A(2): possible implications for atherogenesisP Sartipy, E Hurt-Camejo
Investigacion Clinica|June 22, 2001
[Why are plasmatic apoB lipoproteins atherogenic? The hypothesis of response to retention]E Hurt-Camejo, G Camejo
Arteriosclerosis, Thrombosis, and Vascular Biology|December 16, 1998
Phospholipase A2 type II binds to extracellular matrix biglycan: modulation of its activity on LDL by colocalization in glycosaminoglycan matrixesP Sartipy, G Bondjers, E Hurt-Camejo
Current Opinion in Lipidology|October 26, 2000
Phospholipase A2 and small, dense low-density lipoproteinE Hurt-Camejo, G Camejo, P Sartipy
Atherosclerosis|June 11, 1998
Lysophosphatidylcholine induces the production of IL-1beta by human monocytesY Liu-Wu, E Hurt-Camejo, O Wiklund
Journal of Internal Medicine|May 15, 2001
Cell adhesion molecules and secretory type II phospholipase A2 in relation to carotid atherosclerosis in patients with hypercholesterolaemiaO Wiklund, J Hulthe, G Bondjers, et al.
Circulation Research|April 4, 2000
Molecular basis for the association of group IIA phospholipase A(2) and decorin in human atherosclerotic lesionsP Sartipy, B Johansen, K Gâsvik, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 29, 1998
Ultrastructural localization of secretory type II phospholipase A2 in atherosclerotic and nonatherosclerotic regions of human arteriesM Romano, E Romano, S Björkerud, et al.
The Journal of Biological Chemistry|August 28, 1999
Phospholipase A(2) modification of low density lipoproteins forms small high density particles with increased affinity for proteoglycans and glycosaminoglycansP Sartipy, G Camejo, L Svensson, et al.
The Journal of Biological Chemistry|May 16, 2000
Interferon-gamma induces secretory group IIA phospholipase A2 in human arterial smooth muscle cells. Involvement of cell differentiation, STAT-3 activation, and modulation by other cytokinesH Peilot, B Rosengren, G Bondjers, et al.
Pageof 4